By far, our most important asset is an exceptional depth of knowledge and experience that enables us to design novel and effective drug delivery systems built on a fundamental scientific and technical understanding of our clients’ requirements. Quay Pharma offer every client a bespoke approach matched precisely to their needs and circumstances. We know that a university department researching new drug applications has different needs from a major manufacturer developing a new chemical entity, because we work regularly with both. Over the past decade we have successfully developed safe, robust and effective new products for more than 100 clients, across a spectrum of projects that range from hard-to-deliver New Chemical Entities to reformulations of established drugs, many of them now either successfully licensed or in the latter stages of clinical development. We have also helped with the successful development of a wide range of generic products, medical devices and veterinary products. Significantly, we have often devised successful formulations where other companies have failed. Please contact: enquiries@quaypharma.com
View Top Employees from SGS Quay PharmaWebsite | https://www.sgsquaypharma.com/ |
Revenue | $26 million |
Employees | 130 (130 on RocketReach) |
Founded | 2002 |
Phone | +44 1244 837000 |
Fax | +44 1244 281283 |
Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
Industry | Manufacturing, Pharmaceutical Manufacturing, Manufacturing General, Biotechnology, Dosage Form Optimisation, Science and Engineering, Solubility Enhancement, Controlled Release Technologies, Medical, Drug Formulation and Analytical Development, Health Care, Oral Drug Delivery, Pharmaceutical, Topical Products, Clinical Manufacturing, Clinical Packaging and Supply (Phase I/II), API in Capsule - Xcelolab |
Web Rank | 22 Million |
Competitors | Alpex Pharma SA, CoreRx, Inc., DELPHARM GAILLARD, Metrics Contract Services, QPharma AB |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular SGS Quay Pharma employee's phone or email?
The SGS Quay Pharma annual revenue was $26 million in 2024.
Neil Dankievitch is the General Manager, CDMO of SGS Quay Pharma.
130 people are employed at SGS Quay Pharma.
The NAICS codes for SGS Quay Pharma are [3254, 32541, 325, 32].
The SIC codes for SGS Quay Pharma are [283, 28].